TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors

Abstract

High TrkC mRNA expression in PNET is a powerful independent predictor of favorable clinical outcome. Assessment of TrkC mRNA levels may aid in treatment planning for patients with PNETs and should be incorporated prospectively into PNET clinical trials.